SCHEMBL5776534

SCHEMBL5776534

CCCC(F)(F)C[C@H](NC(=O)N1CCCOCC1)C(=O)N[C@@H](CC)C(=O)c1nc(C2CC2)no1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CTSS P25774 18/20 0.38
CTSK P43235 10/20 0.38
CTSB P07858 3/20 0.38
CTSL P07711 6/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13937547 0.97 CTSS (0.39) CTSSCTSKCTSBCTSL
SCHEMBL8294651 0.91 CTSS (0.37) CTSSCTSKCTSBCTSL
SCHEMBL13937554 0.89 CTSS (0.38) CTSSCTSKCTSL
SCHEMBL6262797 0.88 CTSS (0.39) CTSSCTSKCTSBCTSL
SCHEMBL8291901 0.86 CTSS (0.38) CTSSCTSKCTSBCTSL
SCHEMBL13937553 0.85 CTSS (0.45) CTSSCTSKCTSBCTSL
SCHEMBL8291580 0.84 CTSS (0.40) CTSSCTSKCTSBCTSL
SCHEMBL13937549 0.82 CTSS (0.40) CTSSCTSKCTSBCTSL
SCHEMBL3884984 0.79
SCHEMBL3873326 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682524-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2006-07-26 EP claimed
WO-2005040142-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2005-05-06 WO claimed
US-7482448-B2 Compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2009-01-27 US disclosed
US-7482448-B2 Compounds and compositions as cathepsin inhibitors AVENTIS PHARMACEUTICALS INC. (US) 2009-01-27 US disclosed